Table 2 Details of docking results between 621 natural compounds from Danggui Beimu Kushen Wan and 21 targets for prostate cancer (kcal/mol).

From: Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer

Target ID

Target name

Total binding score

Min

25% percentile

Med

75% percentile

Max

Ave

SD

SEM

95% confidence interval of mean

Top 1 compound

Lower

Upper

T01

TP53

− 3773.0

− 9.1

− 6.8

− 5.8

− 4.7

− 2.9

− 5.76

1.29

0.05

− 5.86

− 5.66

KB032

T02

PTEN

− 4704.0

− 11.0

− 8.4

− 7.3

− 5.8

− 3.3

− 7.18

1.59

0.06

− 7.30

− 7.06

KB031

T03

PTGS2

− 4877.5

− 12.0

− 8.7

− 7.5

− 6.0

− 2.9

− 7.45

1.81

0.07

− 7.59

− 7.31

KA090

T04

HIF1A

− 3628.0

− 8.3

− 6.2

− 5.5

− 4.9

− 2.6

− 5.54

1.01

0.04

− 5.62

− 5.46

KB030

T05

BCL2

− 4604.1

− 11.5

− 8.2

− 7.3

− 6.0

− 2.4

− 7.03

1.47

0.06

− 7.14

− 6.92

KB031

T06

BAX

− 4020.8

− 9.3

− 7.0

− 6.3

− 5.2

− 2.9

− 6.14

1.17

0.05

− 6.23

− 6.05

KB034

T07

CASP3

− 4331.2

− 11.4

− 7.7

− 6.8

− 5.4

− 3.2

− 6.61

1.46

0.06

− 6.72

− 6.50

KB032

T08

ICAM1

− 3619.5

− 8.9

− 6.5

− 5.6

− 4.5

− 2.6

− 5.53

1.29

0.05

− 5.62

− 5.43

KA065

T09

IL1B

− 3839.6

− 8.9

− 6.9

− 6.0

− 4.6

− 2.4

− 5.86

1.36

0.05

− 5.97

− 5.76

KA165

T10

IL2

− 3861.2

− 8.7

− 6.7

− 5.9

− 5.1

− 2.6

− 5.89

1.07

0.04

− 5.98

− 5.81

KB033

T11

GNRHR

− 4426.3

− 11.0

− 7.7

− 6.8

− 5.7

− 2.9

− 6.76

1.37

0.05

− 6.86

− 6.65

ZA08

T12

AR

− 4280.4

− 9.5

− 7.5

− 6.7

− 5.7

− 2.6

− 6.53

1.21

0.05

− 6.63

− 6.44

KA013

T13

CYP17A1

− 4643.2

− 12.5

− 8.4

− 7.2

− 5.6

− 2.8

− 7.09

1.72

0.07

− 7.22

− 6.96

KB031

T14

TUBB1

− 4435.2

− 10.7

− 8.0

− 6.9

− 5.5

− 2.7

− 6.77

1.54

0.06

− 6.89

− 6.65

KB032

T15

TUBA4A

− 4330.8

− 9.7

− 7.8

− 6.8

− 5.4

− 2.9

− 6.61

1.4

0.05

− 6.72

− 6.50

KE012

T18

LHCGR

− 4530.2

− 11.4

− 8.2

− 7.1

− 5.5

− 3.0

− 6.92

1.63

0.06

− 7.04

− 6.79

KA165

T19

PDCD1

− 3793.4

− 8.5

− 6.6

− 5.9

− 5.0

− 2.7

− 5.79

1.08

0.04

− 5.87

− 5.71

KA165

T20

CYP19A1

− 4745.1

− 13.3

− 8.2

− 7.4

− 6.2

− 2.8

− 7.24

1.44

0.06

− 7.35

− 7.13

ZB27

T21

NR1I2

− 4844.4

− 12.1

− 8.5

− 7.6

− 6.2

− 2.6

− 7.40

1.6

0.06

− 7.52

− 7.27

KB034

T22

AHR

− 4329.0

− 10.4

− 7.7

− 6.7

− 5.5

− 2.8

− 6.61

1.39

0.05

− 6.72

− 6.50

KB031

T23

CYP21A2

− 4873.3

− 11.7

− 8.6

− 7.7

− 6.1

− 2.8

− 7.44

1.64

0.06

− 7.57

− 7.31

KB030

  1. Corresponding target full names refer to Table 1. Corresponding compound names refer to Supplementary Tables S1 to S3 online.
  2. Ave average value, Max maximum, Med median value, Min minimum, SD standard deviation, SEM standard error of mean.